Assignee profile:

MAP Pharmaceuticals, Inc.

City:

Mountain View, California

Country:

United States

Published Applications:

33

Last publication date:

2014-06-26

Patent Grants:

25

Last grant date:

2015-03-03

Top Inventors for applications by MAP Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to MAP Pharmaceuticals, Inc.:

Recent patent applications by MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals, Inc. based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-06-26
US20140179707A1
Human necessities

NOVEL ERGOLINE DERIVATIVES AND USES THEREOF

#2 | 2014-05-01
US20140120165A1
Human necessities

CORTICOSTEROID PARTICLES AND METHOD OF PRODUCTION

#3 | 2014-04-03 ✅ Patent 8,969,374 granted on 2015-03-03
US20140094483A1
Chemistry; metallurgy

Iso-ergoline derivatives

#4 | 2014-03-27
US20140086994A1
Human necessities

Synthesis of Small Particles

#5 | 2014-03-13 ✅ Patent 8,841,448 granted on 2014-09-23
US20140073790A1
Chemistry; metallurgy

Fluoroergoline analogs

#6 | 2014-03-13 ✅ Patent 8,933,093 granted on 2015-01-13
US20140073647A1
Chemistry; metallurgy

Fluoroergoline analogs

#7 | 2014-03-06 ✅ Patent 8,927,567 granted on 2015-01-06
US20140066450A1
Chemistry; metallurgy

Fluoroergoline analogs

#8 | 2014-02-06 ✅ Patent 8,722,699 granted on 2014-05-13
US20140039188A1
Chemistry; metallurgy

Iso-ergoline derivatives

#9 | 2014-01-23 ✅ Patent 9,161,912 granted on 2015-10-20
US20140023595A1
Human necessities

Inhalation devices and related methods for administration of sedative hypnotic compounds

#10 | 2013-12-26 ✅ Patent 9,012,640 granted on 2015-04-21
US20130345253A1
Human necessities

Cabergoline derivatives

#11 | 2013-11-21 ✅ Patent 9,216,259 granted on 2015-12-22
US20130306061A1
Human necessities

Methods and apparatus for delivering aerosolized medication

#12 | 2013-06-27 ✅ Patent 8,946,420 granted on 2015-02-03
US20130165469A1
Chemistry; metallurgy

Neuromodulatory compounds

#13 | 2013-06-20 ✅ Patent 8,592,445 granted on 2013-11-26
US20130158064A1
Chemistry; metallurgy

Iso-ergoline derivatives

#14 | 2012-12-27 ✅ Patent 8,604,035 granted on 2013-12-10
US20120329806A1
Chemistry; metallurgy

Fluoroergoline analogs

#15 | 2012-09-27
US20120245179A1
Human necessities

Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile

#16 | 2012-05-31 ✅ Patent 8,574,630 granted on 2013-11-05
US20120135046A1
Human necessities

Corticosteroid particles and method of production

#17 | 2012-04-19 ✅ Patent 8,609,611 granted on 2013-12-17
US20120090604A1
Human necessities

Synthesis of small particles

#18 | 2012-03-22
US20120067343A1
Human necessities

Aerosol Composition for Administering Drugs

#19 | 2011-06-30 ✅ Patent 9,227,030 granted on 2016-01-05
US20110155129A1
Human necessities

Enhanced eductor design

#20 | 2011-06-23 ✅ Patent 8,710,092 granted on 2014-04-29
US20110152280A1
Chemistry; metallurgy

Substituted indolo 4,3 FG quinolines useful for treating migraine

#21 | 2010-11-11 ✅ Patent 8,119,639 granted on 2012-02-21
US20100284940A1
Human necessities

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#22 | 2010-09-30 ✅ Patent 8,147,730 granted on 2012-04-03
US20100247655A1
Human necessities

Synthesis of small particles

#23 | 2010-08-05 ✅ Patent 8,555,875 granted on 2013-10-15
US20100192945A1
Human necessities

Inhalation devices and related methods for administration of sedative hypnotic compounds

#24 | 2010-07-22
US20100183725A1
Human necessities

MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS COMBINED IN DISCRETE INHALATION PARTICLES AND FORMULATIONS THEREOF

#25 | 2010-04-01
US20100081664A1
Human necessities

METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE

#26 | 2010-04-01 ✅ Patent 7,994,197 granted on 2011-08-09
US20100081663A1
Human necessities

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#27 | 2010-01-14 ✅ Patent 8,517,009 granted on 2013-08-27
US20100006096A1
Human necessities

Methods and apparatus for delivering aerosolized medication

#28 | 2009-06-18 ✅ Patent 8,486,043 granted on 2013-07-16
US20090157037A1
Human necessities

Inhalation drug delivery

#29 | 2009-01-01 ✅ Patent 8,475,845 granted on 2013-07-02
US20090004282A1
Performing operations; transporting

Method of particle formation

#30 | 2008-11-20 ✅ Patent 8,148,377 granted on 2012-04-03
US20080287451A1
Human necessities

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#31 | 2008-05-22
US20080118442A1
Human necessities

Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation

#32 | 2006-07-13 ✅ Patent 7,862,751 granted on 2011-01-04
US20060151900A1
Human necessities

Formulation of fine particles using liquefield or dense gases

#33 | 2005-07-28 ✅ Patent 7,641,823 granted on 2010-01-05
US20050163723A1
Human necessities

Synthesis of small particles

Also check out Map Pharmaceuticals, Inc.'s (Mountain View, United States) applicant profile with 9 patent applications submitted.

AssigneeID:

27252 ⎘